665-CRTAM:免疫检查点阻断治疗中解耦疗效与毒性的新靶点 episode artwork

EPISODE · Mar 19, 2026 · 24 MIN

665-CRTAM:免疫检查点阻断治疗中解耦疗效与毒性的新靶点

from 聊聊Sci

这项研究揭示了 CRTAM 分子在免疫检查点阻断治疗中作为特定免疫相关副作用(irAEs)控制点的关键作用。研究团队通过分析转录组和临床数据发现,抑制 CRTAM 能够有效减轻如肠炎和肺炎等免疫毒性症状,且不会削弱免疫治疗对肿瘤的打击力度。实验表明,CRTAM+ T细胞会利用 CADM1 受体优先浸润正常组织而非肿瘤,并诱导导致组织炎症的3型免疫反应。通过遗传敲除或药物阻断 CRTAM-CADM1 轴,科研人员成功实现了免疫治疗中“减毒不减效”的平衡。此外,监测血液中的 CRTAM 相关免疫指标,也为临床预测和评估免疫治疗副反应提供了新的生物标志物。References: Ma S C, Rong Z X, Xu Z P, et al. CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off[J]. Nature Cancer, 2026: 1-17.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Mar 19, 2026

Embed this episode

Ready to play

665-CRTAM:免疫检查点阻断治疗中解耦疗效与毒性的新靶点

0:00 24:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 24 minutes long.

When was this 聊聊Sci episode published?

This episode was published on March 19, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!